Lung diseases due to external agents

J10_EXTERLUNG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J60-J70 Cause of death: ICD-10 — J60-J70 2 out of 7 registries used, show all original rules.	5428
4. Check minimum number of events None	5428
5. Include endpoints J10_COALPNEUMOC J10_ASBESTPNEUMOC J10_SILICAPNEUMOC J10_INORGPNEUMOC J10_NASPNEUMOC J10_TUBERCPNEUMOC J10_AIRWDISDUST J10_HYPERSPNEUMONI J10_CHEMGASRESP J10_PNEUMONISOLLIQ J10_RESPCONDEXT	5920
6. Filter based on genotype QC (FinnGen only)	5920

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	J10_EXTERLUNG
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	J10_COALPNEUMOC\|J10_ASBESTPNEUMOC\|J10_SILICAPNEUMOC\|J10_INORGPNEUMOC\|J10_NASPNEUMOC\|J10_TUBERCPNEUMOC\|J10_AIRWDISDUST\|J10_HYPERSPNEUMONI\|J10_CHEMGASRESP\|J10_PNEUMONISOLLIQ\|J10_RESPCONDEXT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J[6-7]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J[6-7]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Lung diseases due to external agents based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	65050	24383	39593
Only index persons	45747	17975	27772
Unadjusted period prevalence (%)
Whole population	0.95	0.70	1.11
Only index persons	0.90	0.66	1.06
Median age at first event (years)
Whole population	69.66	71.27	68.59
Only index persons	67.86	68.54	67.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5920	1886	4034
Unadjusted period prevalence (%)	1.42	0.64	1.78
Median age at first event (years)	66.83	60.10	69.97

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5316: Matched controls
53150

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

4385.6

323.0

2670

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

641.9

323.0

676

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.2

320.5

2438

11118

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.5

262.7

1514

5442

J70.2

ICD-10 Finland

Acute drug-induced interstitial lung disorders

+∞

245.7

234

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

10.3

242.5

500

528

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

+∞

235.1

224

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.0

212.5

1514

6192

J69.8

ICD-10 Finland

Pneumonitis due to other solids and liquids

1853.6

195.9

189

UGC12

NOMESCO Finland

Flexible bronchoscopy

3.9

192.0

889

2591

T36

ICD-10 Finland

Poisoning by systemic antibiotics

7.7

189.5

467

659

J67.0

ICD-10 Finland

Farmer lung

+∞

183.4

175

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

9.6

180.1

385

429

AA1AD

NOMESCO Finland

CT of head and brain

2.5

165.3

1727

8632

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

5.3

164.4

539

1102

J67.9

ICD-10 Finland

Hypersensitivity pneumonitis due to unspecified organic dust

1631.5

159.1

154

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

135.7

2582

16638

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.9

129.3

911

3547

H02AB06

ATC

prednisolone; systemic

2.0

118.6

2634

17689

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

5.8

114.7

346

634

N05AH04

ATC

quetiapine; oral

2.6

112.9

958

4141

4950A

ICD-9 Finland

Extrinsic allergic alveolitis, Farmers' lung

+∞

110.8

106

TGC00

NOMESCO Finland

Bronchial lavation

6.1

109.4

315

544

N03AG01

ATC

valproic acid; systemic, rectal

4.0

108.1

467

1246

WX730

NOMESCO Finland

Conventional respirator

7.9

108.1

258

342

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.7

107.6

844

3478

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.9

98.2

436

1189

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.4

94.6

495

1544

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

89.2

841

3805

JDB10

NOMESCO Finland

Percutaneous gastrostomy

8.8

88.2

195

228

4959X

ICD-9 Finland

Extrinsic allergic alveolitis, Unspecified allergic alveolitis and pneumonitis

+∞

87.7

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.5

86.5

434

1307

J01MA12

ATC

levofloxacin; systemic

2.1

85.2

1230

6762

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

3.0

85.0

541

1936

5010A

ICD-9 Finland

Asbestosis[ASBESTOSIS]

+∞

83.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

4.3

83.5

327

792

C03CA01

ATC

furosemide; systemic

1.8

83.5

2150

14568

51610

ICD-8 Finland

Other pneumoconiosis and related diseases, Due to inhalation of other dust

+∞

81.4

5070A

ICD-9 Finland

Pneumonitis due to solids and liquids, Due to inhalation of food or vomitus

+∞

80.4

R06.0

ICD-10 Finland

Dyspnoea

1.9

79.9

1452

8697

WX892

NOMESCO Finland

Monitored bed care

2.8

78.3

561

2162

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.6

77.7

653

2760

TPH07

NOMESCO Finland

Cathetrisation of artery

2.5

76.7

689

3019

R13

ICD-10 Finland

Dysphagia

3.0

76.7

474

1657

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

76.3

1612

10144

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.5

76.2

683

2990

R50.9

ICD-10 Finland

Fever, unspecified

2.2

74.5

851

4198

XG410

NOMESCO Finland

Flow-volume spirometry

3.6

73.3

349

1004

A06AD11

ATC

lactulose; oral

2.0

72.1

1103

6150

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.9

70.3

454

1633

J01MA14

ATC

moxifloxacin; systemic

2.5

69.7

593

2516

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

68.8

341

1013

N05BA04

ATC

oxazepam; oral

1.9

68.2

1283

7699

N05AX08

ATC

risperidone; systemic

2.5

67.7

597

2579

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

7.2

67.4

169

241

WX872

NOMESCO Finland

Intensive care

3.1

66.6

392

1323

J62.8

ICD-10 Finland

Pneumoconiosis due to other dust containing silica

+∞

65.7

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

65.5

941

5094

N05BA01

ATC

diazepam; systemic, rectal

2.2

65.5

798

4033

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.1

65.0

214

432

J66.8

ICD-10 Finland

Airway disease due to other specific organic dusts

+∞

64.7

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

4.8

64.6

228

496

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

64.3

844

4398

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

4.6

62.6

228

513

N06AX11

ATC

mirtazapine; oral

1.8

62.4

1516

9850

N03AX14

ATC

levetiracetam; systemic

4.7

61.9

219

478

R03BB04

ATC

tiotropium bromide; inhalant

2.1

61.7

771

3928

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

61.3

1163

6963

J96.0

ICD-10 Finland

Acute respiratory failure

6.1

60.9

173

293

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.5

60.6

537

2321

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.0

60.5

383

1355

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

5.7

60.5

181

327

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.7

60.3

462

1842

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

59.9

1669

11268

N05AH03

ATC

olanzapine; systemic

3.2

59.4

341

1129

R03AC02

ATC

salbutamol; inhalant

1.6

59.2

2405

17988

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

58.0

2228

16393

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.0

57.7

867

4752

N05AA02

ATC

levomepromazine; systemic

3.2

57.1

318

1030

N03AX09

ATC

lamotrigine; oral

3.9

56.4

243

641

J70.4

ICD-10 Finland

Drug-induced interstitial lung disorders, unspecified

+∞

56.3

A02BC02

ATC

pantoprazole; systemic

1.6

56.2

3134

25261

N06AB04

ATC

citalopram; systemic

1.8

56.2

1079

6459

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.7

55.7

398

1520

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

55.2

388

1467

N05CF01

ATC

zopiclone; oral

1.6

54.6

1772

12409

J68.0

ICD-10 Finland

Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours

188.5

54.0

J68.3

ICD-10 Finland

Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours

+∞

53.2

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

52.6

946

5522

R53

ICD-10 Finland

Malaise and fatigue

1.8

52.4

1134

7034

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

51.3

1589

10944

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

51.2

1050

6396

J70.3

ICD-10 Finland

Chronic drug-induced interstitial lung disorders

+∞

51.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

50.6

732

3939

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

4.6

49.9

181

406

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

48.7

791

4439

N07BB01

ATC

disulfiram; oral

3.4

48.3

250

767

N02AA05

ATC

oxycodone; systemic

1.8

48.0

903

5334

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

6.5

47.8

128

201

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

4.6

47.4

171

381

N06AX16

ATC

venlafaxine; oral

2.2

47.2

543

2649

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

4.6

46.7

167

369

G41.9

ICD-10 Finland

Status epilepticus, unspecified

9.6

46.1

102

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.7

45.9

338

1312

J63.3

ICD-10 Finland

Graphite fibrosis (of lung)

+∞

45.9

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

45.7

787

4501

N05CD07

ATC

temazepam; oral

1.8

45.7

845

4951

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.8

45.6

868

5139

N05AX12

ATC

aripiprazole; systemic

4.2

45.6

180

439

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.6

45.6

352

1404

N05AH02

ATC

clozapine; systemic

6.0

45.3

129

220

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.8

45.2

156

332

J96.1

ICD-10 Finland

Chronic respiratory failure

3.5

44.9

223

662

J62.0

ICD-10 Finland

Pneumoconiosis due to talc dust

+∞

44.8

J69

ICD-10 Finland

Pneumonitis due to solids and liquids

98.9

44.8

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

44.4

289

1040

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

44.3

513

2507

J45.1

ICD-10 Finland

Nonallergic asthma

2.5

44.3

385

1639

TJD20

NOMESCO Finland

Change of gastrostomy tube

12.3

44.2

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

43.7

799

4658

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.9

43.2

146

304

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

43.0

349

1431

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.4

42.5

401

1779

R4130

NOMESCO Finland

Speech therapy

4.2

41.9

166

406

L28

ICPC

Limited function/disability (L)

1.8

41.9

899

5516

F10.25

ICD-10 Finland

Alcohol dependence continuous use

4.9

41.6

141

295

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

41.5

846

5106

N03AX16

ATC

pregabalin; oral

1.7

41.3

1074

6974

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

41.1

289

1090

N03AF01

ATC

carbamazepine; oral, rectal

2.5

40.9

346

1450

GBB00

NOMESCO Finland

Tracheostomy

5.2

40.7

130

255

N03AE01

ATC

clonazepam; systemic

2.5

40.4

331

1363

WX882

NOMESCO Finland

High dependency care

3.3

40.4

211

652

F10.09

ICD-10 Finland

Alcohol intoxication UNS

4.4

40.0

150

348

J68.9

ICD-10 Finland

Unspecified respiratory condition due to chemicals, gases, fumes and vapours

+∞

39.6

J70.1

ICD-10 Finland

Chronic and other pulmonary manifestations due to radiation

+∞

39.6

I50.9

ICD-10 Finland

Heart failure, unspecified

1.7

39.3

1021

6618

R11

ICD-10 Finland

Nausea and vomiting

2.2

38.8

422

2003

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

38.7

200

613

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.0

38.4

141

F29

ICD-10 Finland

Unspecified nonorganic psychosis

3.7

38.3

174

481

J67.8

ICD-10 Finland

Hypersensitivity pneumonitis due to other organic dusts

380.0

38.1

J69.1

ICD-10 Finland

Pneumonitis due to oils and essences

+∞

37.5

N05AF03

ATC

chlorprothixene; systemic

3.8

37.0

164

444

SPAT1254

SPAT

Administration of medicine

1.7

36.7

808

4978

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

36.7

1021

6724

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4.9

36.6

124

260

A28

ICPC

Limited function/disability NOS

1.7

36.3

936

6036

F05.9

ICD-10 Finland

Delirium, unspecified

3.4

35.9

182

550

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

6.5

35.6

146

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

35.4

741

4488

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

35.2

723

4356

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

6.9

35.2

130

N04AA02

ATC

biperiden; systemic

4.1

35.2

143

359

C07AB07

ATC

bisoprolol; oral

1.4

35.0

2524

20527

JN4AD

NOMESCO Finland

Body CT examination

2.1

34.8

419

2077

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

4.7

34.5

120

259

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

5.2

34.4

110

217

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

33.9

1190

8294

JN4BD

NOMESCO Finland

Extensive body CT

1.8

33.8

588

3351

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.8

33.7

230

853

D21

ICPC

Swallowing problem

4.6

33.6

120

266

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

4.4

33.6

125

289

B18.2

ICD-10 Finland

Chronic viral hepatitis C

7.2

33.2

116

F10.24

ICD-10 Finland

Alcohol depence active use

5.1

33.0

107

214

J01DA01

ATC

[U] cefalexin; systemic

1.4

33.0

2965

25011

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

7.6

32.9

104

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

5.5

32.0

176

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

31.8

857

5575

N05AN01

ATC

lithium; oral

3.9

31.6

135

355

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

31.5

517

2885

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.4

31.4

285

1239

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

31.3

964

6491

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

5.4

31.1

182

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.2

31.0

191

P15

ICPC

Chronic alcohol abuse

3.4

30.9

154

460

Z57.2

ICD-10 Finland

Occupational exposure to dust

11.0

30.9

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.0

30.9

184

625

K90

ICPC

Stroke/cerebrovascular accident

2.8

30.7

211

783

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

6.5

30.7

126

R40.2

ICD-10 Finland

Coma, unspecified

5.0

30.7

100

202

WX704

NOMESCO Finland

Intubation

2.1

30.5

345

1663

R41.0

ICD-10 Finland

Disorientation, unspecified

2.5

30.3

239

965

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

4.2

30.3

118

286

N05AB03

ATC

perphenazine; systemic, rectal

2.9

30.2

192

682

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.0

30.1

414

2162

N03AF02

ATC

oxcarbazepine; oral

2.9

30.0

190

673

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

11.1

29.9

N02AX02

ATC

tramadol; systemic, rectal

1.4

29.6

2014

16018

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

29.6

370

1859

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

29.4

929

6283

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

29.3

387

1988

R81

ICPC

Pneumonia

2.8

29.3

196

719

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

2.9

29.2

189

676

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

5.8

29.1

147

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

29.1

478

2665

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.2

29.1

312

1469

A02BC05

ATC

esomeprazole; systemic

1.4

29.0

1742

13528

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.1

29.0

350

1735

G72.8

ICD-10 Finland

Other specified myopathies

3.5

28.6

136

392

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

4.2

28.6

110

264

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.9

28.3

460

2554

J01DB01

ATC

cefalexin; oral

1.4

28.3

3703

32926

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.3

27.9

259

1138

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

27.9

798

5258

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

27.5

806

5342

N06AA09

ATC

amitriptyline; systemic

1.8

27.4

467

2634

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

27.4

1328

9865

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

27.3

233

981

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.2

27.3

150

483

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

27.0

173

617

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.0

26.9

362

1873

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.3

26.7

252

1116

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

5.3

26.6

160

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.3

26.6

251

1112

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.5

26.6

126

363

S06.0

ICD-10 Finland

Concussion

1.8

26.6

478

2748

N06AX21

ATC

duloxetine; oral

1.9

26.4

397

2143

SPAT1262

SPAT

Handing over of treatment supplies

1.6

26.3

879

6005

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.7

26.1

101

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

26.1

202

807

ZX120

NOMESCO Finland

Intravenous

1.8

26.1

466

2670

N06AB10

ATC

escitalopram; oral

1.6

26.1

703

4551

51620

ICD-8 Finland

Other pneumoconiosis and related diseases, Due to inhalation of fumes

+∞

26.1

V03AA01

ATC

3.8

25.9

113

304

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.2

25.8

237

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

13.0

25.6

N06AB06

ATC

sertraline; oral

1.9

25.5

395

2155

N05AD01

ATC

haloperidol; systemic

2.4

25.5

226

969

J96.9

ICD-10 Finland

Respiratory failure, unspecified

6.3

25.4

109

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

25.2

1022

7294

J70.9

ICD-10 Finland

Respiratory conditions due to unspecified external agent

+∞

25.0

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.7

24.9

WX722

NOMESCO Finland

PEEP

2.2

24.7

264

1241

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.0

24.7

147

499

A02BC01

ATC

omeprazole; systemic

1.4

24.6

1360

10322

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.7

24.6

175

666

J01FA06

ATC

roxithromycin; oral

1.4

24.5

1741

13821

R4110

NOMESCO Finland

Physiotherapy

1.5

24.5

1157

8514

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

4.1

24.4

241

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.2

24.3

251

1163

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

4.9

24.2

165

N03AX18

ATC

lacosamide; systemic

7.2

24.2

R03BA05

ATC

fluticasone; inhalant

1.6

24.2

750

5026

K92.0

ICD-10 Finland

Haematemesis

2.6

24.2

180

704

J63.8

ICD-10 Finland

Pneumoconiosis due to other specified inorganic dusts

+∞

24.0

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.4

23.9

208

886

SPAT1240

SPAT

Therapeutic discussion

2.0

23.8

330

1724

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.6

23.7

182

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

6.5

23.6

N05AA01

ATC

chlorpromazine; systemic, rectal

4.1

23.5

230

J01FF01

ATC

clindamycin; systemic

1.4

23.5

1172

8707

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.0

23.3

311

1603

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

4.7

23.2

173

Z72.2

ICD-10 Finland

Drug use

12.1

23.2

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

3.7

23.1

104

288

N02BE01

ATC

paracetamol; systemic, rectal

1.4

23.1

3968

36151

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.4

23.0

128

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

5.0

23.0

153

L04AX01

ATC

azathioprine; systemic

2.5

22.9

186

763

M05BA04

ATC

alendronic acid; oral

1.8

22.9

396

2244

R55

ICD-10 Finland

Syncope and collapse

1.6

22.9

587

3743

SPAT1255

SPAT

Intravenous administration of medicine

1.9

22.8

336

1798

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.9

22.7

368

2039

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

22.6

1422

11024

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

14.2

22.5

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

8.5

22.5

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

22.4

325

1730

N87

ICPC

Parkinsonism

3.4

22.4

111

333

P16

ICPC

Acute alcohol abuse

4.0

22.2

228

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

22.1

480

2918

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

22.0

242

1152

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

9.8

22.0

A04

ICPC

Weakness/tiredness general

1.6

22.0

599

3883

R04.2

ICD-10 Finland

Haemoptysis

2.2

21.9

225

1039

J60

ICD-10 Finland

Coalworker pneumoconiosis

+∞

21.9

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

6.2

21.9

R03BA02

ATC

budesonide; inhalant

1.5

21.9

726

4939

XA800

NOMESCO Finland

Neuropsychological investigation

2.5

21.8

176

720

R47.1

ICD-10 Finland

Dysarthria and anarthria

4.3

21.8

189

F60.9

ICD-10 Finland

Personality disorder, unspecified

5.3

21.8

128

N03AX12

ATC

gabapentin; oral

1.6

21.8

630

4142

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

4.5

21.6

177

J47

ICD-10 Finland

Bronchiectasis

3.1

21.6

119

386

N05BA02

ATC

chlordiazepoxide; systemic

2.7

21.5

146

542

S01.0

ICD-10 Finland

Open wound of scalp

1.8

21.2

399

2321

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.7

21.1

155

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.8

21.1

139

508

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

21.0

323

1756

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

20.9

196

866

R05

ICD-10 Finland

Cough

1.5

20.8

766

5330

N30.0

ICD-10 Finland

Acute cystitis

1.6

20.8

561

3620

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

20.8

698

4752

R03BA01

ATC

beclometasone; inhalant

1.6

20.7

629

4182

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.7

20.7

143

535

R33

ICD-10 Finland

Retention of urine

1.6

20.7

530

3376

N05AF05

ATC

zuclopenthixol; systemic

4.7

20.6

154

B01AB05

ATC

enoxaparin; parenteral

1.4

20.5

1315

10190

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

20.5

240

1173

183

Kela drug reimbursment

Lamotrigin and topiramate

5.8

20.5

101

F61.0

ICD-10 Finland

Mixed personality disorders

4.2

20.2

185

1240

FHL

Bronchoscopy

3.2

20.2

108

344

M03BX01

ATC

baclofen; systemic

3.5

20.1

280

SPAT1229

SPAT

Assessment of need for aid

1.7

20.1

418

2506

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

8.4

20.1

N05AC02

ATC

thioridazine; oral

3.2

20.1

108

345

K56.0

ICD-10 Finland

Paralytic ileus

3.9

20.1

215

N06AX03

ATC

mianserin; oral

2.1

20.1

233

1137

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

19.9

365

2107

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

4.5

19.9

160

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.4

19.9

283

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.8

19.9

222

J63.4

ICD-10 Finland

Siderosis

+∞

19.8

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.1

19.7

218

1040

N29

ICPC

Neurological sympt/complt other

3.1

19.5

108

352

R4120

NOMESCO Finland

Occupational therapy

1.9

19.5

278

1471

A04AA02

ATC

granisetron; systemic, transdermal

2.0

19.5

255

1307

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

19.4

583

3866

G40

ICD-10 Finland

Epilepsy

5.3

19.3

113

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.7

19.2

131

489

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.0

19.2

112

379

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

2.2

19.1

200

934

N06AB03

ATC

fluoxetine; oral

1.6

19.0

468

2944

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

19.0

290

1572

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.0

19.0

260

1355

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.3

18.9

180

801

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

18.9

451

2818

H02AB04

ATC

methylprednisolone; systemic

1.5

18.8

621

4206

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

2600

14253

2.47

241.18

6.2

4.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1469

7466

2.29

148.23

4.8

3.1

mmol/l

0.8

4.63

1371

6895

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1575

8378

2.20

141.20

2.5

1.8

—

(3023419) Bacteria identified in Sputum by Culture

297

593

5.22

140.59

2.9

2.4

—

(3003396) Base excess in Arterial blood by calculation

1217

5876

2.35

137.31

9.8

6.6

mmol/l

1.8

1.1

6.34

975

4480

(3023183) Ammonium ion [Moles/volume] in Plasma

381

960

4.17

135.24

2.6

2.7

umol/l

33.0

35.1

0.61

328

793

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

414

1128

3.87

131.83

1.8

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

403

1079

3.93

131.54

1.8

1.5

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1199

5903

2.29

128.36

9.9

6.6

kpa

5.2

5.1

4.92

1122

5576

(3027801) Oxygen [Partial pressure] in Arterial blood

1196

5901

2.29

127.27

9.9

6.6

kpa

10.7

11.9

15.99

1123

5568

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

615

2207

2.99

126.15

2.4

1.8

ug/l

2.6

2.4

0.11

542

1893

(3019060) Gas panel - Arterial blood

827

3476

2.60

125.34

7.2

4.4

—

(3009343) pH of Capillary blood

786

3295

2.60

119.44

5.8

3.7

7.4

0.44

122

397

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

769

3195

2.62

119.00

5.7

3.6

mmol/l

2.6

1.7

7.12

609

2279

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

324

796

4.25

118.74

1.7

1.4

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

205

342

6.17

117.48

2.0

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

522

1778

3.12

117.01

3.0

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

788

3343

2.57

116.67

5.8

3.7

kpa

5.3

5.1

5.08

738

3052

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1230

6350

2.18

115.98

6.2

5.8

mmol/l

1.0

2.88

1127

5838

(3028707) Methadone [Presence] in Urine by Screen method

209

363

5.93

114.94

5.3

2.8

—

(3016502) Oxygen saturation in Arterial blood

1061

5292

2.22

108.30

10.6

6.9

93.9

95.3

7.99

1009

5076

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

792

3486

2.47

107.95

1.9

1.6

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

272

640

4.41

105.34

1.7

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

314

823

3.97

105.27

1.8

1.6

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

267

662

4.18

96.49

1.9

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

260

636

4.23

95.65

1.6

1.4

—

(1616796) Gas panel - Central venous blood

372

1168

3.33

95.04

4.7

3.9

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1089

5752

2.09

94.81

2.4

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

275

723

3.94

91.69

1.6

1.4

—

(3010421) pH of Blood

393

1311

3.14

90.76

6.2

4.5

7.4

0.92

343

1120

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1078

5771

2.06

90.07

2.4

1.7

—

(3006315) Basophils [#/volume] in Blood

2917

21295

1.73

89.75

7.7

5.5

e9/l

0.0

1.10

2596

18179

(42870588) Differential panel, method unspecified - Blood

2201

14851

1.77

89.63

7.7

5.6

—

(3001604) Monocytes [#/volume] in Blood

2895

21167

1.72

87.91

7.7

5.5

e9/l

0.7

0.6

8.45

2584

18046

(3009466) Valproate [Moles/volume] in Serum or Plasma

241

595

4.18

87.53

5.8

4.6

umol/l

350.2

348.0

0.07

214

502

(3019198) Lymphocytes [#/volume] in Blood

2946

21711

1.71

86.31

7.9

5.6

e9/l

1.7

1.9

5.21

2640

18816

(3027315) Oxygen [Partial pressure] in Blood

354

1145

3.22

86.03

6.3

4.7

kpa

8.0

8.3

3.75

344

1120

(3012501) Base excess in Blood by calculation

353

1141

3.23

85.88

6.3

4.7

mmol/l

2.8

2.6

0.61

281

753

(3013290) Carbon dioxide [Partial pressure] in Blood

353

1142

3.22

85.76

6.3

4.7

kpa

5.1

5.0

0.90

343

1118

(3013115) Eosinophils [#/volume] in Blood

2970

21981

1.70

85.27

8.5

5.7

e9/l

0.2

6.84

2668

19005

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2859

20948

1.71

85.17

9.9

6.0

mmol/l

1.2

6.08

2630

18802

(3019069) Monocytes/100 leukocytes in Blood

2767

20103

1.71

85.00

8.6

6.1

8.7

8.9

2.78

2623

18624

(3022096) Basophils/100 leukocytes in Blood

2698

19475

1.71

84.84

8.0

5.8

0.5

0.6

17.47

2560

18000

(3006504) Eosinophils/100 leukocytes in Blood

2751

20006

1.70

83.80

8.1

5.8

2.4

2.9

20.10

2605

18463

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3105

23348

1.69

83.21

8.4

6.0

umol/l

11.6

12.5

2.36

2968

22091

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

222

537

4.26

82.83

2.0

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

906

4686

2.10

82.42

7.9

6.8

mmol/l

9.9

11.3

6.80

849

4419

(3002030) Lymphocytes/100 leukocytes in Blood

2796

20528

1.69

81.32

8.4

5.9

22.8

26.2

45.33

2637

18893

(3008152) Bicarbonate [Moles/volume] in Arterial blood

692

3262

2.27

79.35

11.2

6.5

mmol/l

25.3

24.4

7.61

646

3051

(3022313) Gas panel - Capillary blood

552

2378

2.46

77.69

6.3

3.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

338

1130

3.11

77.59

1.9

1.5

—

(4198724)

106

9.09

77.55

4.0

1.6

—

(3042631) Mycobacterium sp identified in Specimen

258

731

3.64

77.12

2.9

2.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

650

3025

2.29

76.72

1.8

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2057

14079

1.71

76.57

3.3

2.2

u/l

268.1

238.2

0.64

1942

13143

(3018010) Neutrophils/100 leukocytes in Blood

2733

20182

1.66

75.90

8.0

5.7

62.1

58.5

40.86

2587

18673

(3020191) Ethanol [Moles/volume] in Serum or Plasma

157

307

5.23

75.89

1.8

1.3

promille

1.3

1.2

0.12

120

241

(3032080) INR in Blood by Coagulation assay

2710

20031

1.65

74.51

13.7

11.0

inr

1.3

1.4

1.28

851

5494

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2036

13982

1.69

74.32

3.3

2.5

u/l

57.9

59.0

0.32

1899

12901

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

619

2890

2.27

72.32

9.2

6.8

mmol/l

25.3

24.7

2.78

609

2866

(3002173) Hemoglobin [Mass/volume] in Arterial blood

882

4752

2.01

70.96

12.1

7.4

g/l

120.1

120.7

0.32

847

4579

(3013650) Neutrophils [#/volume] in Blood by Automated count

3174

24606

1.62

70.56

13.0

8.4

e9/l

4.8

4.3

21.49

2854

21296

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3019

23130

1.62

70.34

10.1

6.8

mmol/l

1.2

4.08

2435

19368

(3014111) Lactate [Moles/volume] in Serum or Plasma

839

4488

2.01

68.72

8.8

6.3

mmol/l

1.5

1.4

0.98

798

4270

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

429

1736

2.59

68.71

2.9

2.3

ug/l

425.0

668.7

1.03

401

1648

(1001926) Buprenorphine [Presence] in Urine by Screen method

230

656

3.61

68.03

4.7

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

314

1090

2.99

67.40

3.4

2.5

16.1

15.9

0.41

164

571

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2500

18436

1.62

67.04

5.9

4.1

ng/l

48.0

93.4

1.15

2039

13925

(3011288) Drugs identified in Urine by Screen method

203

553

3.77

64.24

6.5

2.9

—

(3042936) Bacteria identified in Isolate by Culture

1103

6616

1.82

63.32

2.3

2.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

460

2011

2.40

62.27

7.1

4.1

mmol/l

25.5

24.7

6.79

428

1822

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

100

154

6.59

61.94

13.7

13.8

nmol/l

829.2

814.3

0.09

146

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

100

154

6.59

61.94

1.7

2.4

umol/l

77.2

145.0

1.16

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

166

413

4.11

59.63

1.8

1.5

—

(3016879) Cocaine [Presence] in Urine

245

793

3.18

59.28

5.0

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2641

20119

1.56

59.20

6.4

4.8

g/l

32.5

34.7

58.43

2414

18514

(3000764) Benzodiazepines [Presence] in Urine

251

841

3.07

57.26

5.2

2.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

549

2688

2.15

56.49

11.0

8.5

mmol/l

24.7

24.3

1.98

510

2471

(3036481) Cortisol [Moles/volume] in Serum or Plasma

677

3584

2.00

56.44

2.5

2.2

nmol/l

362.3

376.3

0.77

615

3267

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

130

279

4.74

56.39

1.8

1.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

212

648

3.36

56.32

1.2

1.1

—

(44790047)

178

490

3.71

55.48

1.9

1.4

—

(44790049)

178

490

3.71

55.48

1.9

1.4

—

(44790048)

178

490

3.71

55.48

1.9

1.4

—

(44806118)

178

490

3.71

55.48

1.9

1.4

—

(3027008) Opiates [Presence] in Urine

249

848

3.02

55.20

5.2

2.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

148

6.30

54.64

1.7

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

323

1271

2.63

54.57

5.2

3.1

kpa

7.8

7.9

0.19

304

1177

(3013826) Glucose [Moles/volume] in Serum or Plasma

3316

26864

1.53

54.29

8.7

4.8

mmol/l

7.0

6.9

1.83

3172

25248

(3021447) Carbon dioxide [Partial pressure] in Venous blood

848

4898

1.85

54.29

4.7

3.6

kpa

6.0

5.8

3.74

810

4721

(3028300) Cannabinoids [Presence] in Urine

248

851

3.00

54.25

5.3

2.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

140

329

4.33

54.23

1.7

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

128

281

4.63

54.02

1.8

1.5

—

(3002032) Base excess in Venous blood by calculation

845

4886

1.85

53.88

4.7

3.6

mmol/l

2.5

1.9

5.85

715

3878

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

754

4242

1.89

52.29

2.8

2.1

g/l

0.2

2.61

676

3914

(3015235) Bicarbonate [Moles/volume] in Capillary blood

343

1419

2.50

52.21

4.0

3.2

mmol/l

25.5

24.8

1.97

318

1227

(3018418) pH of Serum or Plasma

1883

13588

1.57

51.72

5.1

4.0

7.4

1.88

510

2582

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

165

453

3.72

51.63

1.6

1.5

—

(3026782) Osmolality of Urine

1422

9639

1.63

50.75

3.6

2.9

mosm/kgh2o

531.4

560.8

6.26

1262

8229

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

157

424

3.78

50.32

1.6

—

(3012544) pH of Venous blood

855

5066

1.80

50.06

4.7

3.7

7.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

714

4002

1.89

49.96

4.3

3.0

kpa

4.7

4.5

1.72

675

3842

(3000991) Gas panel - Venous blood

739

4210

1.86

49.10

10.8

7.6

—

(3027944) Amphetamines [Presence] in Urine

234

826

2.91

48.64

5.2

2.0

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

134

331

4.12

48.62

1.2

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

568

3003

1.99

47.16

3.1

2.6

g/l

10.3

10.7

0.75

506

2723

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1830

13335

1.54

47.14

4.6

3.1

u/l

38.1

37.1

0.19

1715

12553

(3021901) Oxygen saturation in Capillary blood

268

1046

2.64

45.97

3.5

2.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

830

5003

1.77

45.53

5.3

3.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

391

1828

2.22

44.92

6.8

3.7

mmol/l

1.6

1.4

1.49

379

1797

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1142

7538

1.64

44.60

2.2

2.0

30.3

0.05

1099

7293

(3026008) Bacteria identified in Urine by Culture

1874

13857

1.52

44.51

4.1

3.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

401

1911

2.18

43.91

1.5

1.6

u/ml

14.5

17.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2050

15532

1.49

42.87

3.8

3.2

ng/l

2033.1

1967.7

0.23

1806

13430

(3019309) Folate [Moles/volume] in Red Blood Cells

1453

10275

1.55

41.99

2.1

1.8

nmol/l

1206.9

1160.7

1.05

1082

7646

(3007853) Bacteria identified in Skin by Aerobe culture

857

5333

1.71

41.69

2.2

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

969

6239

1.66

41.42

10.9

6.5

mmol/l

104.0

104.4

1.81

933

6085

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

395

1917

2.14

41.25

3.4

2.9

u/ml

0.3

0.00

243

1088

(3006184) Hemoglobin [Mass/volume] in Capillary blood

275

1145

2.47

41.22

2.6

2.3

g/l

130.1

127.3

0.91

208

842

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

224

849

2.70

40.72

3.9

3.6

61.2

59.0

1.49

224

849

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

125

345

3.68

38.86

1.8

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

453

2367

1.99

38.67

1.8

1.9

g/l

1.3

1.4

0.66

401

2121

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

112

6.04

38.34

1.2

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3436

29133

1.43

37.52

6.4

4.8

e6/l

1278.6

1697.4

0.25

103

539

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

552

3114

1.85

37.36

13.7

8.4

0.7

0.56

544

3089

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

322

1506

2.20

36.87

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

1424

10267

1.51

36.81

3.5

2.7

e6/l

5.3

4.5

1.66

1310

9019

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

210

815

2.63

36.43

8.2

4.9

iu/ml

426.8

2596.6

0.58

114

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

643

3846

1.75

35.73

5.7

4.0

mmol/l

1.2

1.73

588

3338

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

104

269

3.92

35.50

2.0

2.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

9.59

35.02

1.1

1.3

mmol/l

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

544

3121

1.82

34.78

13.8

8.3

1.5

1.3

3.73

536

3101

(1175426) CD3 cells/100 lymphocytes in Blood

106

286

3.76

34.10

2.0

2.1

72.6

71.1

0.36

267

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

104

277

3.80

34.08

2.0

2.1

14.9

14.4

0.10

120

(3043409) Potassium [Moles/volume] in Arterial blood

320

1541

2.14

34.02

7.6

4.0

mmol/l

3.9

0.16

283

1427

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

105

284

3.75

33.66

3.6

3.7

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1666

12582

1.45

33.51

2.6

2.3

mg/l

3.4

3.1

5.16

1412

10560

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

7.95

33.20

1.4

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

129

403

3.25

33.15

1.4

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

129

403

3.25

33.15

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

129

403

3.25

33.15

1.4

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1276

9167

1.50

33.03

2.0

1.7

mg/l

1.5

0.23

1026

7101

(3002582) Erythrocytes [#/volume] in Urine

1875

14530

1.42

32.58

4.3

3.5

e6/l

88.7

112.6

0.34

1569

11447

(40760892) CBC W Ordered Manual Differential panel - Blood

1222

8733

1.50

32.37

6.0

4.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

297

1419

2.15

32.21

1.7

—

(21494815) CD4 cells/100 lymphocytes in Specimen

106

300

3.58

31.81

2.1

2.2

35.7

45.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

307

1494

2.11

31.75

1.9

1.6

titre

572.5

212.6

0.94

(3019977) pH of Arterial blood

107

306

3.54

31.61

3.3

2.3

7.4

0.34

109

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

23.08

31.46

1.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

658

4099

1.68

31.33

2.8

1.7

1.5

3.68

563

3542

(3047181) Lactate [Moles/volume] in Blood

311

1538

2.08

30.82

10.0

5.8

mmol/l

1.3

0.21

258

1353

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

441

2461

1.86

30.74

4.6

3.7

mmol/l

24.7

24.0

4.24

403

2202

(3011412) CD3 cells [#/volume] in Blood

119

371

3.25

30.71

2.0

2.2

e9/l

1.1

0.27

219

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

878

5913

1.57

30.38

3.3

4.0

u/l

251.9

246.8

0.36

819

5540

(3020891) Body temperature

377

2011

1.93

30.18

9.0

4.6

—

(3017181) Myelocytes/100 leukocytes in Blood

605

3729

1.69

29.92

4.2

4.0

1.0

0.9

0.15

247

1124

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

177

697

2.59

29.85

1.6

1.3

—

(3042517) Benzodiazepines panel - Urine

13.39

29.66

2.8

2.3

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

466

2677

1.80

29.53

14.7

9.3

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1097

7808

1.50

29.28

2.7

2.5

umol/l

10.9

12.4

11.60

984

7173

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

758

4973

1.60

29.26

3.3

2.7

umol/l

10.0

9.5

0.26

636

4339

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

979

6839

1.52

28.52

2.8

2.6

19.6

22.2

7.88

796

5769

(3044640) Blood type and Crossmatch panel - Blood

1804

14141

1.40

28.46

3.2

2.6

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

774

5135

1.58

28.44

1.9

1.7

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3812

33644

1.37

28.37

11.1

7.5

u/l

84.8

81.2

3.36

3621

31503

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

518

3108

1.73

28.22

2.1

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1028

7273

1.50

28.14

2.7

2.5

g/l

2.2

2.3

0.15

924

6681

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

247

1159

2.18

28.04

1.7

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

247

1159

2.18

28.04

1.7

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

737

4854

1.59

27.91

1.4

1.3

titre

443.0

497.4

0.40

187

1011

(3027945) Reticulocytes/100 erythrocytes in Blood

905

6246

1.53

27.84

2.8

2.4

1.8

1.7

1.97

774

5428

(3003181) Sodium [Moles/volume] in Urine

195

833

2.39

27.65

1.7

1.3

mmol/l

64.4

63.3

0.11

151

669

(3005322) IgE [Units/volume] in Serum or Plasma

377

2070

1.88

27.61

1.5

1.3

u/ml

260.3

233.6

0.19

336

1891

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

7.40

27.11

2.4

3.3

umol/l

41.3

38.4

0.28

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

129

4.77

27.05

1.9

1.5

iu/ml

1520143.8

1504762.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

8.04

26.85

2.6

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

142

4.54

26.78

3.4

2.6

umol/l

30.5

29.6

0.12

101

(3002179) Metamyelocytes/100 leukocytes in Blood

545

3364

1.68

26.70

4.0

3.9

0.9

0.7

1.04

188

789

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

390

2189

1.84

26.63

2.4

2.0

—

(40761536) Microorganisms panel - Urine sediment

577

3638

1.65

26.03

5.3

4.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

712

4733

1.57

25.80

2.8

2.4

ug/l

9.0

7.0

0.77

590

4029

(3033658) Prothrombin time (PT) actual/Normal

1460

11209

1.40

25.49

5.9

4.1

83.1

83.9

0.53

1414

10920

(3030467) Casts [#/volume] in Urine by Automated count

1669

13110

1.38

25.38

4.2

3.3

e6/l

0.5

0.33

1384

10109

(36304419) Bacteria [Presence] in Urine

1611

12602

1.38

25.07

4.2

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

436

2578

1.75

24.95

4.6

3.5

mmol/l

25.7

25.1

3.05

418

2491

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

131

4.54

24.69

2.1

—

(3018095) Leukocytes [#/volume] in Urine

2011

16325

1.35

24.64

4.9

3.9

e6/l

109.7

111.0

0.02

1621

12126

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

242

3.51

24.61

1.5

1.3

u/ml

1.9

1.1

0.34

120

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

160

659

2.47

24.61

6.4

6.3

mg/l

11.6

12.1

0.79

143

598

(3021440) Promyelocytes/100 leukocytes in Blood

559

3546

1.64

24.57

4.3

4.0

0.1

0.11

231

1046

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3721

41093

0.75

24.55

5.0

5.1

mmol/l

2.5

2.6

10.22

3277

37223

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

358

2007

1.83

24.52

2.2

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1891

15217

1.36

24.50

3.8

3.3

mmol/l

2.3

4.17

1616

13053

(3004119) Hemoglobin [Mass/volume] in Venous blood

502

3103

1.67

24.40

4.3

3.2

g/l

125.5

127.7

1.27

484

3022

(3000494) Fungus identified in Specimen by Culture

713

4799

1.55

24.38

1.8

1.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

3402

29850

1.33

24.21

5.8

4.4

—

(3020630) Protein [Mass/volume] in Serum or Plasma

651

4300

1.58

24.17

2.4

2.5

g/l

65.5

66.0

0.67

577

3849

(3025159) Blasts/100 leukocytes in Blood

522

3281

1.65

23.77

4.3

4.1

0.0

0.3

1.40

202

860

(3006576) Bicarbonate [Moles/volume] in Blood

183

3.86

23.65

6.2

6.7

mmol/l

25.8

24.7

1.11

169

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3622

40012

0.76

22.79

4.6

mmol/l

4.3

4.4

12.07

3231

36442

(3044290) Cell count panel - Cerebral spinal fluid

167

734

2.31

22.25

1.7

1.4

—

(21494814) CD8 cells/100 lymphocytes in Specimen

151

4.07

22.23

2.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

140

570

2.49

22.11

1.4

1.6

g/l

0.7

0.9

1.95

101

443

(3024139) IgG subclass 3 [Mass/volume] in Serum

100

344

2.94

21.92

1.3

g/l

0.4

0.16

250

(3027135) IgG subclass 1 [Mass/volume] in Serum

100

344

2.94

21.92

1.3

g/l

7.0

6.8

0.16

248

(3028192) IgG subclass 2 [Mass/volume] in Serum

100

345

2.93

21.81

1.3

g/l

2.8

3.0

0.59

251

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3594

39616

0.76

21.27

4.6

4.5

mmol/l

1.3

1.4

10.65

3181

35826

(3017509) Phencyclidine [Presence] in Urine

10.04

21.14

3.3

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

148

633

2.37

21.00

3.8

2.6

u/ml

53454.3

2619.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

179

830

2.19

20.99

1.4

1.3

mmol/l

4.1

3.9

1.77

168

767

(40758558) Short blood count panel - Blood

1381

10794

1.36

20.94

10.0

6.4

—

(4062490)

348

2.88

20.89

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

186

3.63

20.81

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

358

2109

1.74

20.72

8.8

4.9

1.7

1.6

1.57

322

1977

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

183

3.64

20.54

2.1

1.6

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

11.70

20.45

5.3

8.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

391

2369

1.70

20.44

5.3

4.1

51.1

47.4

2.16

383

2335

(3039000) Anion gap in Blood

217

1100

2.01

20.14

12.1

6.6

mmol/l

10.7

11.4

2.12

188

981

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

3.52

20.13

1.2

1.1

—

(3018572) Chloride [Moles/volume] in Blood

217

1101

2.01

20.09

12.1

6.6

mmol/l

104.4

105.2

1.19

188

982

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

192

935

2.09

19.88

1.5

1.3

mg/l

674.0

575.4

0.30

179

877

(4010399)

455

2894

1.62

19.68

1.5

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

384

2339

1.69

19.67

3.4

2.6

0.7

2.13

377

2241

(3017143) Hepatitis C virus Ab [Presence] in Serum

569

3822

1.54

19.45

1.7

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

176

3.61

19.41

1.5

1.7

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

176

3.61

19.41

1.5

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2960

25936

1.28

19.11

4.8

3.1

u/l

68.2

54.5

6.37

2731

23722

(3007930) Methemoglobin/Hemoglobin.total in Blood

347

2074

1.71

19.06

9.0

4.9

0.9

1.35

312

1946

(3040151) Glucose [Moles/volume] in Capillary blood

142

626

2.30

18.84

9.0

19.2

mmol/l

7.1

7.6

1.58

121

507

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

204

3.36

18.80

1.2

1.1

—

(4015189)

123

4.09

18.42

2.1

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

213

1108

1.96

18.38

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

178

3.51

18.35

1.5

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

127

540

2.38

18.31

3.8

3.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

990

7479

1.39

18.23

26.7

29.5

inr

1.5

0.23

1033

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

157

3.66

17.95

1.5

1.8

u/ml

3773.6

22018.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2088

17628

1.28

17.67

3.3

2.9

ug/l

161.0

155.3

0.46

1859

15988

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

227

1224

1.89

17.61

1.4

iu/ml

6.8

14.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2345

20120

1.27

17.32

5.3

4.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

108

4.19

17.14

2.4

2.3

nmol/l

165.4

145.5

0.50

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

238

3.05

17.01

1.5

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

238

3.05

17.01

1.5

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

238

3.05

17.01

1.5

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

238

3.05

17.01

1.5

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1211

9535

1.34

17.00

5.1

4.1

ng/l

342.8

529.4

0.86

1000

8091

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

578

4005

1.49

16.98

3.2

2.4

u/l

32.4

50.2

0.85

497

3403

(3029937) Albumin [Presence] in Urine by Test strip

1425

11498

1.32

16.83

5.4

4.2

estimate

0.0

1.49

516

3655

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

156

3.55

16.61

3.9

2.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

156

3.55

16.61

3.9

2.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

258

2.93

16.54

3.0

2.4

—

(3023520) Reticulocytes [#/volume] in Blood

654

4673

1.45

16.40

2.6

2.5

e9/l

71.2

67.7

1.57

517

3583

(3052851) Hemolysis interference index of Serum or Plasma

249

1416

1.79

16.30

4.5

3.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

223

1228

1.85

16.22

2.8

2.4

g/l

3.9

3.6

2.14

214

1166

(40757373) Influenza virus identified in Isolate

113

4.00

16.16

2.0

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

120

2521

0.47

15.86

1.5

1.8

—

(3014271) Vancomycin [Susceptibility]

316

2.68

15.70

4.2

2.9

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

7.21

15.66

1.1

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

607

4316

1.45

15.59

1.7

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

515

3575

1.48

14.95

2.1

2.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

159

804

2.00

14.95

1.5

e6/l

483.5

946.6

0.76

131

665

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

159

805

2.00

14.89

1.5

1.4

e6/l

33.3

23.4

0.17

122

637

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

297

2.68

14.81

1.7

1.2

mmol/l

2.3

2.1

0.76

276

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3530

38381

0.80

14.80

4.2

4.1

mmol/l

1.3

3.60

3128

34427

(3008295) Osmolality of Serum or Plasma

105

453

2.34

14.73

1.4

1.3

mosm/kgh2o

280.3

278.8

0.20

338

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

274

1652

1.69

14.61

2.0

1.8

u/l

40.8

37.7

1.16

248

1419

(21494755) Public health laboratory ask at order entry panel

117

2407

0.48

14.58

1.3

1.4

—

(3028433) Virus identified in Specimen by Culture

136

3.55

14.56

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

650

4741

1.42

14.49

3.9

3.1

ng/l

268.8

260.8

0.15

595

4340

(3021879) Hepatitis B virus core Ab [Presence] in Serum

375

2452

1.56

14.41

1.5

1.4

—

(3051651) Icteric interference index of Serum or Plasma

268

2.75

14.34

5.0

3.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1266

10253

1.30

14.19

1.8

1.7

pmol/l

15200466.6

26460402.4

0.46

1000

8322

(3004809) Band form neutrophils/100 leukocytes in Blood

161

834

1.96

14.15

3.3

3.6

1.5

1.6

0.24

136

615

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

189

3.09

14.11

2.1

1.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1977

16918

1.25

14.09

2.6

2.2

nmol/l

76.3

77.8

1.41

1715

14841

(3016018) Differential panel - Cerebral spinal fluid

364

2.47

14.07

1.9

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

138

678

2.06

14.06

1.7

1.8

ug/l

16.7

24.6

2.61

131

666

(3015171) Extractable nuclear Ab [Units/volume] in Serum

226

1307

1.76

14.01

1.3

1.2

u/ml

0.4

0.7

0.90

124

(3036489) Thrombin time

256

1533

1.70

14.01

2.3

2.0

21.6

0.00

230

1386

(3046861) Legionella sp Ag [Presence] in Urine

7.94

14.01

1.2

1.0

—

(3006245) CD3-CD19+ cells/100 cells in Blood

131

3.53

13.86

2.0

2.1

10.9

11.8

0.12

117

(3007164) IgA [Mass/volume] in Serum or Plasma

888

6863

1.35

13.84

1.7

1.5

g/l

2.8

2.6

1.70

565

4087

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

186

1018

1.85

13.84

2.0

1.9

mg/l

10.8

12.3

1.19

175

932

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1316

10746

1.29

13.79

3.1

2.5

—

(4035726)

526

3728

1.45

13.70

1.5

1.4

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

360

2.44

13.43

1.2

1.1

—

25.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

162

857

1.92

13.40

1.5

g/l

31.0

30.8

0.08

145

758

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

109

499

2.21

13.34

3.2

3.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

209

1199

1.77

13.34

2.5

2.3

88.0

88.3

0.06

202

1137

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

384

2582

1.52

13.00

1.7

g/l

1.7

1.5

1.67

311

2181

(1761868) Lipid panel - Serum or Plasma

1025

12700

0.77

12.97

3.4

3.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

188

1054

1.81

12.97

1.7

1.4

g/l

0.2

0.19

180

996

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1423

16925

0.79

12.91

4.1

4.6

21.4

22.1

1.02

692

8696

(3024928) Oxygen saturation in Venous blood

187

1051

1.80

12.80

2.2

2.7

—

(40768806) Pleura Pathology biopsy report

131

656

2.02

12.71

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

101

3.78

12.68

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1639

0.41

12.60

1.4

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

206

1203

1.74

12.38

3.6

3.1

nmol/l

0.8

1.18

162

891

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

964

11967

0.77

12.27

2.8

3.2

ug/l

0.8

0.13

673

8354

(44816559) Phosphatidylethanol [Mass/volume] in Blood

129

652

2.00

12.22

1.8

1.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

371

2.34

12.14

1.2

—

(3021589) Normoblasts [#/volume] in Blood

2115

18455

1.23

12.10

17.4

10.0

e9/l

0.0

0.06

1762

15033

(3017569) Oxygen content in Arterial blood

276

2.55

12.01

2.2

2.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1868

16103

1.23

11.97

5.4

4.1

—

(3000060) B lymphocytes [#/volume] in Blood

3.92

11.97

1.8

2.0

e6/l

333.5

1628.2

0.66

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

259

2.60

11.96

1.9

2.3

e6/l

443.4

530.2

0.67

218

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

110

3.56

11.96

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

101

3.68

11.90

1.1

—

(3025941) Bacteria identified in Stool by Culture

324

2143

1.54

11.85

1.4

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

111

3.53

11.81

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

188

1089

1.75

11.65

1.8

1.4

g/l

1.2

1.24

179

1027

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

132

3.27

11.59

1.9

2.1

29.7

28.9

0.11

122

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

236

2.64

11.43

2.4

2.7

42.5

36.1

1.11

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

5.90

11.31

1.1

1.2

—

(3013512) EKG study

1589

13529

1.24

11.31

5.3

4.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1326

11082

1.25

11.13

4.6

3.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3396

31199

1.21

11.08

5.6

4.1

mm/h

17.9

13.7

31.24

3149

28538

(3007566) Smooth muscle Ab [Titer] in Serum

177

1025

1.75

11.00

1.2

titre

100.0

93.8

0.12

(3035637) Corticotropin [Mass/volume] in Plasma

103

499

2.08

10.99

1.9

1.6

—

(3016038) Potassium [Moles/volume] in Urine

313

2.38

10.96

1.4

1.1

mmol/l

31.8

35.3

0.72

267

(3016650) Hepatitis A virus Ab [Presence] in Serum

116

588

1.99

10.94

1.1

—

(3012441) Differential panel - Pleural fluid

126

662

1.92

10.72

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.59

10.60

2.1

1.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

165

949

1.76

10.52

1.3

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

205

1260

1.65

10.25

1.5

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

3.32

10.23

1.2

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.54

10.22

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

244

2.52

10.22

2.0

2.3

e9/l

0.2

0.16

215

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

11.02

10.16

1.3

1.2

mmol/l

—

(3035350) Ketones [Presence] in Urine by Test strip

2333

20806

1.20

10.13

4.9

3.8

estimate

0.0

0.80

584

3864

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

138

765

1.82

9.97

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

210

1309

1.63

9.94

2.5

3.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

105

3.35

9.83

1.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

478

3533

1.38

9.80

4.0

3.9

ng/l

93.5

99.4

0.74

397

2999

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.38

9.78

1.2

—

(3037756) Immunofixation for Serum or Plasma

189

1153

1.66

9.75

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

200

1239

1.64

9.71

1.4

ug/g

228.9

270.7

2.47

122

741

(3026250) Tacrolimus [Mass/volume] in Blood

148

2.92

9.62

36.6

33.6

ug/l

7.2

7.3

0.15

134

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

276

2.37

9.60

1.8

2.2

e6/l

430.0

661.7

1.52

116

(3009261) Glucose [Presence] in Urine by Test strip

2355

21093

1.19

9.59

5.0

3.8

estimate

0.0

1.34

558

3758

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.42

9.57

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

180

1095

1.66

9.40

2.3

1.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

180

1095

1.66

9.40

2.7

2.4

224.2

199.8

2.51

170

1044

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

156

913

1.73

9.40

1.5

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

146

839

1.76

9.38

1.2

1.1

—

(40768797) Stomach Pathology biopsy report

722

5713

1.30

9.34

1.3

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

305

2.28

9.31

1.1

1.2

titre

86.7

132.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

299

2.29

9.29

2.3

1.9

—

(3019150) Specific gravity of Urine by Refractometry

1123

9380

1.24

9.28

5.5

4.2

kg/l

1.0

0.08

170

1444

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.77

9.05

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

2316

20795

1.19

8.98

6.5

5.1

estimate

0.0

0.40

582

3913

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3619

38540

0.84

8.96

6.8

6.3

mmol/mol

42.0

40.8

6.93

3217

35124

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

145

845

1.73

8.89

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

126

706

1.80

8.84

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2171

19413

1.19

8.77

2.2

2.1

pmol/l

91.8

92.1

0.12

1204

10392

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

191

2.58

8.71

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

189

1188

1.61

8.70

4.5

3.0

mg/l

1.8

1.7

0.41

159

1069

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

250

1675

1.51

8.69

2.6

3.2

ratio

27.0

3.9

0.45

124

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

255

1716

1.51

8.68

2.6

3.2

mg/l

43.2

58.5

0.87

179

1391

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

121

675

1.81

8.62

1.4

u/ml

99.6

120.5

1.10

143

(3042733) HLA Ab [Presence] in Serum

105

3.15

8.48

4.6

4.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

254

1717

1.50

8.47

2.6

3.2

mg/l

75.2

99.1

0.30

178

1387

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

261

2.31

8.44

1.5

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3788

40111

0.85

8.44

5.1

4.9

mmol/l

6.2

6.1

2.90

3318

35872

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

293

2045

1.46

8.32

3.0

3.2

pmol/l

4.2

4.4

1.99

258

1777

(3051593) INR in Capillary blood by Coagulation assay

282

2.25

8.30

1.8

12.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

167

2.65

8.26

44.8

24.9

ug/l

135.3

113.2

1.18

137

(3023410) Appearance of Cerebral spinal fluid

341

2.12

8.25

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

116

654

1.79

8.01

1.3

1.2

u/ml

288.5

275.1

0.18

398

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.13

7.98

1.9

2.1

umol/l

17.3

18.1

0.11

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

250

2.29

7.89

3.8

3.4

—

(3017732) Neutrophils [#/volume] in Blood

379

2798

1.38

7.85

4.4

3.2

e9/l

4.7

4.2

1.75

248

2035

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

627

4981

1.29

7.84

3.1

4.0

ug/l

8.2

23.1

4.16

526

4148

(3019225) pH of Specimen

602

4761

1.29

7.79

5.3

4.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

156

2.64

7.68

1.2

—

(3003338) MCHC [Mass/volume]

3182

34056

0.86

7.66

38.2

21.5

g/l

330.2

332.1

22.99

3121

33637

(3006653) Thiamine [Moles/volume] in Blood

205

2.40

7.56

1.4

1.2

nmol/l

135.1

138.5

0.17

205

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

147

2.66

7.45

1.2

1.1

ng/l

67.7

265.2

1.32

(3052592) Norovirus Ag [Presence] in Stool

109

2.95

7.37

1.5

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

105

593

1.78

7.25

1.4

1.3

u/l

323.9

385.8

0.33

561

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

179

2.47

7.22

2.6

2.4

umol/l

60.4

55.1

0.44

141

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

537

1.82

7.16

1.1

g/l

1.6

1.5

0.53

481

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

881

10459

0.81

7.12

1.7

1.6

mmol/l

1.5

1.4

2.36

735

8711

(3036782) Glucose [Moles/volume] in Pleural fluid

103

585

1.77

7.00

1.3

1.4

mmol/l

6.6

6.5

0.27

539

(3008757) Leukocyte morphology finding [Identifier] in Blood

100

563

1.79

7.00

4.3

4.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.01

6.90

7.2

2.3

mg/l

2.1

2.7

0.48

(3022493) Free Hemoglobin [Mass/volume] in Plasma

215

2.29

6.83

3.5

4.5

mg/l

4007.2

69.5

0.49

141

(3001893) Eosinophils/100 leukocytes in Pleural fluid

209

2.31

6.81

1.6

1.5

2.6

1.9

0.25

174

(3001964) Herpes simplex virus Ag [Presence] in Specimen

109

2.85

6.77

2.5

1.4

—

(3000492) Spirometry study

455

3534

1.31

6.75

1.8

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

397

1.93

6.74

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.89

6.70

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

106

616

1.73

6.67

1.2

1.1

—

(40761535) Cells panel - Urine sediment

503

3972

1.29

6.59

4.4

3.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

114

684

1.68

6.41

1.5

1.4

e6/l

115299.1

72153.8

0.35

407

(3033705) Calcium.ionized [Moles/volume] in Venous blood

117

710

1.66

6.31

2.9

2.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.84

6.25

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1926

21192

0.86

6.23

4.8

5.3

ug/l

3.8

4.3

0.31

1621

18745

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

186

2.32

6.22

1.3

ug/l

145.4

545.1

0.90

100

(3023199) Leukocytes [#/volume] in Pleural fluid

123

760

1.63

6.19

1.4

1.5

e6/l

1433.4

1750.5

0.55

555

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

448

1.82

6.06

1.3

u/l

10.6

13.5

1.28

407

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.24

5.99

1.0

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.05

5.90

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

154

1018

1.53

5.83

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

484

1.77

5.80

5.0

3.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

170

1149

1.49

5.79

1.5

1.6

iu/ml

0.1

12.9

1.28

265

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.61

5.75

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.61

5.75

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.61

5.75

1.3

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.61

5.75

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1233

0.55

5.71

1.5

1.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1298

11449

1.17

5.71

1.7

1.6

nmol/l

19.1

19.6

0.53

1133

9742

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

281

2.00

5.63

1.1

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

262

2.03

5.56

1.6

1.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

262

2.03

5.56

1.5

68.1

67.7

0.03

212

(3014148) Varicella zoster virus Ab [Titer] in Serum

346

1.89

5.52

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.90

5.45

1.2

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1001

8686

1.18

5.35

3.5

3.1

mmol/l

2.5

6.62

837

7529

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

141

933

1.52

5.35

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

240

2.05

5.29

1.0

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

4429

45830

0.87

5.27

43.7

24.3

g/l

128.9

134.2

81.40

4328

44915

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

108

675

1.61

5.25

1.3

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

4.62

5.25

1.6

1.1

u/field

1.1

0.9

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

214

2.11

5.24

1.1

—

(3007461) Platelets [#/volume] in Blood

4427

45802

0.87

5.22

43.4

24.2

e9/l

246.3

239.2

8.89

4309

44362

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.05

5.21

2.2

—

(3026361) Erythrocytes [#/volume] in Blood

4429

45819

0.87

5.20

43.3

24.2

e12/l

4.3

4.4

47.75

4283

44205

(3035941) MCH [Entitic mass]

4429

45816

0.87

5.18

43.1

24.1

30.2

30.4

9.59

4338

44890

(3024731) MCV [Entitic volume]

4429

45816

0.87

5.18

43.2

24.1

91.5

0.10

4337

44889

(3010813) Leukocytes [#/volume] in Blood

4431

45835

0.87

5.18

43.4

24.2

e9/l

7.5

6.9

24.99

4293

44222

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

202

2.14

5.17

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

115

734

1.58

5.13

3.8

3.4

—

(3024932) HLA-DR beta [Type]

110

2.55

5.03

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.90

5.02

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

171

2410

0.70

4.99

1.4

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

129

2.41

4.95

1.5

1.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

420

1.75

4.87

1.2

u/l

48.5

61.4

1.47

275

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.99

4.82

2.3

2.2

—

(3024471) HLA-A [Type]

113

2.48

4.78

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

483

1.69

4.76

1.1

—

(4027681)

183

2.14

4.73

1.3

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

322

1.84

4.70

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

331

1.82

4.62

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

346

1.80

4.60

2.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

334

1.80

4.50

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

327

1.81

4.49

1.1

—

(3037121) Protein [Mass/volume] in Urine

222

1654

1.36

4.48

3.3

3.0

g/l

0.3

0.20

106

718

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

871

7580

1.17

4.46

3.8

3.2

e6/l

2.1

1.8

0.89

534

4326

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

703

6017

1.19

4.38

1.3

iu/ml

32.9

37.3

0.45

222

1863

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.72

4.36

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

111

732

1.53

4.35

1.4

1.2

u/ml

3.1

7.0

0.53

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

327

1.78

4.20

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

836

0.55

4.15

1.3

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

419

1.68

4.11

1.3

1.4

—

(4306422)

473

1.64

4.10

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

250

1.89

4.10

1.2

1.1

mg/l

89.0

45.1

0.44

199

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3721

38723

0.89

4.08

26.6

15.9

ml/min/173m2

77.3

75.0

6.90

3197

32119

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.63

4.05

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

230

1.92

4.04

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

230

1.92

4.04

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

453

1.64

4.00

2.0

2.1

u/field

1.7

1.6

0.05

177

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

238

1.90

4.00

1.1

mg/l

436.8

299.2

0.37

198

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

128

886

1.45

3.99

1.4

1.2

u/ml

2.0

3.7

1.69

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

6.44

3.98

1.1

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.44

3.98

1.1

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

113

764

1.49

3.97

1.4

1.2

u/ml

5.5

7.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

501

1.60

3.96

1.6

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

129

897

1.45

3.94

1.3

1.2

u/ml

7.6

7.9

0.03

140

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

112

2.33

3.91

1.7

1.5

5.5

6.2

0.14

(1617658) Protocol used for examination of sentinel lymph nodes

212

1.94

3.90

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.89

3.89

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

584

1.55

3.84

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

235

1.88

3.81

1.1

1.2

—

(3035880) pH of Pleural fluid

345

1.72

3.80

1.2

1.3

—

(3024869) Neuronal Ab [Presence] in Serum

2.60

3.80

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

126

880

1.44

3.77

1.5

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

339

1.72

3.75

1.8

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.91

3.73

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

134

952

1.42

3.67

1.4

1.2

u/ml

19.4

41.8

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.61

3.63

1.2

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

138

991

1.40

3.56

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

117

2.23

3.56

8.7

7.0

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.40

3.55

1.5

1.3

19.1

21.1

0.13

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

107

735

1.46

3.52

1.2

1.3

miu/ml

211.1

219.5

0.06

285

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

10.01

3.49

1.0

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

160

1182

1.36

3.49

1.3

1.2

—

(40768793) Breast Pathology biopsy report

622

1.50

3.49

1.5

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

542

1.54

3.48

1.4

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

148

1082

1.38

3.45

4.1

3.7

mg/l

28.8

30.7

0.26

722

(3005988) Vibrio sp identified in Specimen by Organism specific culture

544

1.53

3.43

1.4

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

166

1.99

3.43

2.7

2.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

274

1.76

3.40

2.1

1.7

u/field

1.1

3.0

1.81

199

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4279

44037

0.90

3.39

15.7

10.7

u/l

27.3

26.4

0.80

4123

42121

(3017354) Segmented neutrophils/100 leukocytes in Blood

522

1.54

3.38

2.9

3.5

64.3

58.8

1.44

308

(42529406) Shigella sp [Presence] in Stool by Culture

160

1189

1.36

3.38

1.3

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

231

1.82

3.36

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

158

1173

1.36

3.36

1.3

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

897

7990

1.14

3.35

3.5

3.0

e6/l

1.1

1.2

0.26

560

4702

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

121

2.15

3.31

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

543

1.52

3.25

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

286

1.72

3.23

1.4

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

150

2.00

3.19

2.4

1.5

umol/l

30.6

28.7

0.47

144

(40768795) Lymph node Pathology biopsy report

387

1.61

3.18

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

636

1.47

3.17

2.4

2.1

mg/l

32.7

24.7

0.55

147

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

104

2.22

3.15

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

104

2.22

3.15

1.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4321

41970

1.11

3.11

33.0

16.7

mg/l

31.1

27.2

11.98

3974

34302

(3004451) EKG impression Narrative

260

1.74

3.09

1.4

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

159

1.95

3.08

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.23

3.05

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

432

1.56

3.02

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

233

1.76

2.99

1.4

—

(3013336) Amino acids [Identifier] in Serum or Plasma

10.01

2.98

3.4

6.8

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

555

1.48

2.96

1.4

1.3

—

(4094501)

1094

0.67

2.95

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

119

865

1.38

2.93

1.3

1.4

u/l

11.9

8.9

1.37

704

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.71

2.91

1.5

mg/l

4.8

2.8

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.71

2.91

1.5

mg/l

3.6

2.5

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.71

2.91

1.5

mg/l

3.4

2.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1087

0.68

2.86

2.1

1.7

mg/l

10.2

4.1

1.37

772

(3032057) Clostridioides difficile [Presence] in Stool

129

2.02

2.85

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

439

1.53

2.83

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

505

1.49

2.80

1.2

u/ml

6.2

4.6

0.30

222

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

546

1.47

2.79

1.4

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.65

2.79

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

292

1.65

2.77

1.6

1.7

—

(3021788) Differential panel - Synovial fluid

111

807

1.38

2.75

1.6

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1082

9873

1.12

2.73

4.7

3.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

549

1.46

2.73

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

233

1.72

2.71

1.4

—

(40757494) Bilirubin.total [Moles/volume] in Blood

256

1.68

2.70

2.1

2.2

umol/l

10.5

24.5

—

(3007463) Buprenorphine [Presence] in Urine

6.00

2.69

1.2

3.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.50

2.69

1.2

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

126

1.99

2.64

1.1

1.5

g/l

11.8

14.6

0.77

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

351

1.57

2.63

1.9

1.7

mg/l

3.9

4.6

0.91

332

(3004616) Nuclear Ab [Presence] in Serum

464

1.49

2.61

1.2

—

(44813793)

214

1.73

2.58

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

1318

0.72

2.57

1.1

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.19

2.56

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

2.19

2.56

1.4

1.6

—

(3045716) Anion gap in Serum or Plasma

245

1.68

2.55

2.0

2.2

mmol/l

8.3

9.3

0.87

197

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

267

2205

1.22

2.54

1.2

1.3

au/ml

93.4

61.2

—

100

(3020564) Creatinine [Moles/volume] in Serum or Plasma

4306

44107

0.91

2.53

33.1

19.6

umol/l

84.9

85.6

0.44

4299

44089

(3045142) Bone marrow Pathology biopsy report

534

1.45

2.51

1.5

1.3

—

(3044927) Protein electrophoresis panel - Urine

561

1.43

2.47

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.67

2.44

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

196

1.74

2.42

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.94

2.41

1.1

2.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1310

12157

1.10

2.38

3.4

2.9

umol/l

1880.5

5889.9

5.97

1103

10322

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

6.25

2.37

1.0

u/field

2.6

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

294

3483

0.84

2.36

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

3.64

2.36

1.0

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

477

1.45

2.32

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.31

1.1

1.2

ng/l

234.2

1284.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

325

3800

0.85

2.25

1.6

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.89

2.25

1.0

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

837

7620

1.11

2.21

1.3

1.2

u/ml

1.3

1.9

0.85

198

1931

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

643

1.37

2.19

1.4

1.2

u/ml

38.1

49.9

0.38

(3020393) Adenovirus Ag [Presence] in Stool

2.62

2.18

1.5

1.1

—

(1002224) Polysomnography panel

1267

0.75

2.16

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

402

1.47

2.15

1.5

1.2

u/ml

94.2

37.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

4.29

2.15

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

229

1899

1.21

2.14

2.6

2.2

g/l

10.4

10.3

0.17

175

1583

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.45

2.10

1.1

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

463

1.43

2.08

3.2

3.7

u/ml

28.7

33.8

0.29

445

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

304

0.49

2.08

1.3

1.4

pmol/l

47.3

148.4

—

100

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

153

1.77

2.07

1.3

1.4

23.2

21.3

0.11

125

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

288

2449

1.18

2.06

2.3

2.4

au/ml

54.1

25.2

—

101

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

261

1.57

2.05

1.6

u/l

4.3

6.5

0.43

116

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

515

1.40

2.05

1.2

u/ml

1.8

2.8

0.82

164

(3038071) Oxygen [Partial pressure] in Mixed venous blood

103

1.94

2.04

7.2

7.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.32

2.04

1.1

1.3

ug/l

77.8

113.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

4.00

2.04

2.2

2.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

157

1258

1.25

2.03

2.5

2.3

ug/min

111.2

112.0

0.01

756

(3021387) Prolactin [Units/volume] in Serum or Plasma

113

870

1.30

2.01

1.8

1.6

mu/l

343.5

292.7

0.64

106

801

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

109

838

1.31

1.97

1.4

1.2

u/l

54.7

45.5

0.21

720

(3020682) Albumin/Creatinine [Ratio] in Urine

1376

14647

0.92

1.96

4.2

4.0

mg/mmol

12.9

10.2

1.11

899

9510

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

167

1355

1.24

1.95

2.6

2.2

g/l

0.0

0.00

143

1241

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.55

1.94

1.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

242

2040

1.19

1.93

2.6

2.2

g/l

7.5

7.4

0.70

157

1475

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

224

1875

1.20

1.93

2.6

2.2

g/l

3.3

3.1

2.36

156

1450

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.73

1.93

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.45

1.92

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

234

1.58

1.92

1.2

1.3

nmol/l

1.1

1.2

0.07

176

(36660697) Celiac disease serology panel - Serum

314

2715

1.17

1.86

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

241

2039

1.19

1.86

2.6

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.86

1.86

1.0

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

294

2531

1.17

1.85

2.7

2.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

171

1401

1.23

1.84

5.1

4.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

221

1.59

1.84

2.0

1.5

u/l

5.1

7.1

1.51

190

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

123

971

1.27

1.84

3.2

3.3

u/ml

207.3

879.2

1.44

109

895

(40768441) Liver Pathology biopsy report

277

1.52

1.83

1.7

1.3

—

(3000012) Reticulocyte production index

295

1.50

1.79

1.9

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.34

1.77

1.1

1.0

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

168

1381

1.22

1.77

2.6

2.2

g/l

0.0

1.04

143

1247

(3050129) First trimester maternal screen panel - Serum or Plasma

387

0.59

1.75

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

574

1.35

1.75

2.5

2.2

u/l

3286.7

2994.2

0.04

221

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

139

1.73

1.75

1.2

1.0

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

239

2035

1.18

1.73

2.6

2.2

g/l

3.7

3.8

0.29

154

1420

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.22

1.73

3.1

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

103

803

1.29

1.72

1.4

1.8

iu/l

3.2

4.4

0.72

254

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

290

1.49

1.71

1.7

2.0

nmol/l

17.7

17.5

0.05

267

(3023511) Choriogonadotropin [Units/volume] in Urine

258

1.51

1.70

1.7

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

600

0.68

1.69

1.2

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

202

1700

1.19

1.68

2.6

2.3

g/l

1.1

0.01

158

1432

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

186

1556

1.20

1.66

2.5

2.1

g/l

36.6

37.3

0.90

148

1310

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.58

1.65

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

134

1.72

1.65

2.0

u/l

23.2

45.3

0.77

123

(3013139) Helicobacter pylori Ag [Presence] in Stool

214

2508

0.85

1.61

1.3

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

663

1.30

1.58

1.2

—

(3022621) pH of Urine by Test strip

340

2999

1.14

1.58

3.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

3.00

1.58

5.5

10.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

144

1.67

1.57

1.7

1.9

—

(3049717) Cytology report of Urine Cyto stain

269

2335

1.16

1.57

2.7

2.9

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

114

1.76

1.56

1.6

1.3

nmol/l

173.6

140.4

0.23

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

396

3533

1.13

1.55

3.6

2.8

ml/min/173m2

61.2

61.6

0.06

173

1503

(3008898) HLA-B27 [Presence]

955

0.76

1.54

1.1

—

(3012565) Volume of 24 hour Urine

216

1.53

1.8

2.4

2363.1

1901.8

0.61

182

(3020491) Glucose [Moles/volume] in Blood

331

1.42

1.53

2.6

2.2

mmol/l

8.3

6.9

1.01

220

(42529582) MDA5 Ab [Presence] in Serum by Line blot

100

1.80

1.52

1.3

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

100

1.80

1.52

1.3

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

100

1.80

1.52

1.3

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

100

1.80

1.52

1.3

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

176

1480

1.19

1.51

2.6

2.2

g/l

0.0

1.00

151

1341

(3016750) Collection duration of Urine

299

1.44

1.50

2.4

2.1

min

489.5

489.4

0.00

216

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

618

5665

1.10

1.48

1.3

1.2

u/ml

15.9

13.6

0.25

201

2063

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

228

1964

1.17

1.48

1.2

iu/ml

130.0

136.5

0.08

673

(3012516) Albumin [Mass/volume] in Urine

1310

13829

0.93

1.48

3.4

3.3

mg/l

773.4

330.7

1.78

869

9044

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.50

1.45

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.88

1.44

7.3

7.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

303

1.42

2.7

2.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

181

1.55

1.39

1.1

u/l

1.1

0.09

(4281824)

338

1.39

1.1

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.89

1.38

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.08

1.38

2.1

1.5

umol/l

50.6

45.6

0.29

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

104

1.73

1.36

1.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

197

0.51

1.36

1.2

1.3

mmol/l

5.8

6.1

—

187

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.94

1.36

1.2

1.1

nmol/l

307.0

234.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.94

1.36

6.8

5.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2300

22211

1.06

1.34

3.1

2.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.78

1.32

1.5

ug/l

0.3

0.4

1.09

(3015183) Erythrocyte sedimentation rate

149

0.47

1.31

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

489

1.31

1.5

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.74

1.30

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

194

1672

1.17

1.29

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

454

4133

1.11

1.28

2.0

2.2

ug/g

196.5

162.7

0.72

340

3244

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.78

1.28

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

114

1.67

1.28

1.1

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.08

1.27

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

107

1.68

1.25

1.3

1.4

g/l

21.6

27.2

0.67

(44806071)

2.22

1.24

1.0

—

(3044889) 12 lead EKG panel

2922

29985

0.95

1.23

5.3

4.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.00

1.23

1.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.77

1.22

1.1

—

(3004775) Volume in Urine collected for unspecified duration

427

1.31

1.18

2.5

2.2

622.1

620.7

0.01

266

(3017704) Immunofixation for Urine

298

1.38

1.18

1.2

1.5

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

198

0.55

1.15

1.1

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.05

1.15

1.3

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

272

0.62

1.14

1.1

1.5

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

210

0.57

1.14

4.9

6.3

—

(3014891) Appearance of Pleural fluid

1.69

1.13

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

175

1.49

1.12

1.1

ratio

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.33

1.12

1.0

1.1

—

(4268621)

336

1.34

1.11

2.1

2.3

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

217

1.43

1.11

1.2

1.1

u/l

31.4

34.0

0.10

158

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

151

1296

1.17

1.10

1.5

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.87

1.07

2.0

1.2

56.0

55.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1134

0.83

1.07

1.6

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

3625

36920

0.95

1.06

30.8

17.7

37.2

39.1

16.62

2091

24085

(3023323) Follitropin [Units/volume] in Serum or Plasma

104

867

1.20

1.06

1.4

iu/l

31.0

28.8

0.26

734

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

242

0.62

1.06

1.8

1.7

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.92

1.06

5.0

5.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

313

0.67

1.04

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

313

0.67

1.04

1.2

1.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.96

1.03

24.4

9.7

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.06

1.02

1.1

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

536

1.25

1.01

1.9

2.0

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

537

1.25

1.00

1.5

1.3

nmol/l

0.6

0.16

515

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

123

1.55

0.99

1.1

miu/ml

1476.9

1591.9

0.18

123

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

538

1.25

0.99

1.5

1.3

nmol/l

0.2

0.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

115

1.57

0.99

3.8

3.0

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.80

0.98

1.0

1.3

nmol/l

3.2

532008.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.17

0.98

1.0

1.5

—

(3033799) Differential panel - Peritoneal fluid

148

1.49

0.97

1.3

2.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.85

0.96

1.0

1.1

iu/ml

7.4

13.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

100

1.60

0.96

1.1

1.3

88.5

80.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

631

1.22

0.96

2.0

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

216

1.39

0.95

1.2

1.1

u/l

94.5

93.1

0.02

165

(4034850)

159

1390

1.15

0.94

17.5

11.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

570

1.23

0.93

1.7

1.5

58.8

63.9

0.48

366

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

316

0.69

0.93

1.2

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

257

0.66

0.93

1.3

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

427

1.27

0.92

1.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

315

0.70

0.91

1.2

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

195

1733

1.13

0.91

3.1

3.2

u/ml

242.9

3248.2

1.17

163

1486

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

430

0.74

0.91

1.2

mmol/l

7.3

7.5

0.10

311

(3044941) Cell count panel - Synovial fluid

718

1.20

0.90

1.5

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

692

1.20

0.89

1.1

—

(3005033) Fetal Nuchal fold Thickness US

254

0.67

0.88

1.3

1.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

475

1.24

0.88

1.5

1.3

nmol/l

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

264

0.68

0.86

1.3

1.5

—

(3000475) Leukocytes [#/volume] in Synovial fluid

128

1111

1.16

0.86

1.7

1.6

e6/l

13832.3

16207.7

0.29

792

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.82

0.85

1.0

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

120

1.50

0.85

2.1

2.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

496

1.23

0.84

1.0

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

137

1.46

0.83

1.0

1.1

u/ml

1.1

6.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.76

0.83

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

343

0.73

0.83

1.3

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

435

1.24

0.81

1.8

1.4

30.2

25.6

0.41

276

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.57

0.81

1.4

1.2

mmol/l

0.7

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

621

0.80

0.81

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1.34

0.80

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

232

1.34

0.80

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

232

1.34

0.80

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

215

1.35

0.80

3.6

4.0

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.79

0.0

1.2

—

0.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.82

0.79

1.0

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.53

0.78

1.1

80.9

83.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

220

1992

1.11

0.78

1.5

1.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3683

37359

0.96

0.76

5.0

4.5

mu/l

2.0

2.1

0.93

3266

33498

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

230

2092

1.10

0.75

2.1

1.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1.32

0.75

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1.32

0.75

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

235

1.32

0.75

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.64

0.75

1.6

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.08

0.74

1.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.08

0.74

4.0

3.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

141

1.42

0.74

1.1

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

245

1.31

0.73

1.8

2.0

umol/l

6.6

11.4

0.91

161

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

132

0.61

0.73

1.4

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

167

1.38

0.73

1.3

2.2

e6/l

1371.6

5808.4

0.48

123

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

134

0.60

0.73

1.0

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

107

0.56

0.72

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

4240

42869

0.96

0.71

29.8

16.0

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

168

1.37

0.71

1.2

1.5

ug/l

6.4

9.7

1.36

145

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.92

0.70

1.2

1.0

—

(40768443) Skin Pathology biopsy report

171

1897

0.90

0.70

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.71

0.70

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

292

1.27

0.69

1.1

u/ml

1.8

4.3

1.53

120

(3025577) Chromium [Mass/volume] in Blood

301

1.26

0.69

2.0

ug/l

2.9

2.0

0.49

251

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

251

2310

1.09

0.67

2.2

1.9

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

0.55

0.67

2.6

3.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.63

0.66

1.0

1.2

umol/24h

1.6

1.8

—

(3044009) aPTT.lupus sensitive (LA screen)

1.79

0.66

1.0

1.2

—

(3019174) dRVVT (LA screen)

1.79

0.66

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.50

0.63

1.2

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

101

0.59

0.62

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.67

0.61

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

0.0

—

(4212803)

1.54

0.59

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.44

0.58

1.2

115.1

111.4

0.32

(3045462) Protein/Creatinine [Ratio] in Urine

1.71

0.57

8.8

3.9

g/mol

28.4

24.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

211

1.28

0.57

1.6

1.4

6.2

3.7

0.55

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.67

0.56

1.2

1.3

—

(4211845)

238

1.26

0.56

3.5

3.8

—

(3034426) Prothrombin time (PT)

115

1.39

0.56

1.1

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

346

3677

0.94

0.56

2.6

2.1

nmol/l

11.5

12.2

0.85

294

3190

(40768446) Kidney Pathology biopsy report

141

1.35

0.56

1.9

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

172

0.70

0.56

3.7

2.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.62

0.55

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.62

0.55

2.3

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

302

1.23

0.55

1.4

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

107

1.40

0.55

1.0

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

596

5698

1.05

0.55

12.6

8.3

—

(3036603) Volume of Urine

275

1.24

0.55

1.6

1.7

1819.0

1768.0

0.14

(40768804) Tissue Pathology biopsy report

1622

16610

0.97

0.54

2.3

2.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

285

1.23

0.53

1.1

titre

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.48

0.53

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

599

1.15

0.53

1.0

1.1

iu/ml

3.5

1042.9

0.54

127

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

304

1.22

0.52

1.2

1.4

u/l

27.1

25.7

0.07

250

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3067

30244

1.03

0.52

4.2

3.7

pmol/l

15.0

0.08

2702

26974

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

271

0.77

0.52

2.3

3.6

nmol/l

85.2

164.9

1.64

266

(3035933) Granulocytes/100 leukocytes in Blood

1.45

0.51

7.8

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.45

0.51

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.50

0.51

1.0

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

161

1.31

0.51

1.3

1.2

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

423

0.83

0.50

1.1

u/ml

2.6

2.3

—

157

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

297

1.21

0.50

1.0

ng/l

269.3

321.0

0.83

195

(3044007) Cell count panel - Peritoneal fluid

136

1.32

0.49

1.3

2.1

—

(3022689) Creatine [Moles/volume] in Urine

110

0.64

0.48

1.3

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

155

1.29

0.46

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

150

1380

1.09

0.46

1.1

—

1.3

—

(3011648) Oxygen content in Venous blood

356

1.18

0.45

1.5

2.2

12.4

10.9

1.11

356

(3001729) Color of Synovial fluid

1.40

0.45

2.4

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

152

0.72

0.44

1.4

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

129

0.70

0.43

1.3

1.5

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

175

1.26

0.43

1.1

1.0

iu/ml

15.8

11.8

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

7.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.47

0.40

1.6

1.4

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

399

1.15

0.39

1.5

1.3

nmol/l

1.4

1.5

0.21

355

(3002256) Pathology report gross observation

550

5703

0.96

0.39

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

446

1.14

0.39

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.41

0.39

3.8

2.4

u/field

0.1

0.4

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.39

0.38

2.4

2.8

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.39

0.38

1.2

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

298

1.18

0.38

1.0

ng/l

41.1

45.4

0.29

192

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

905

1.10

0.37

1.1

u/ml

0.7

7.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

299

1.17

0.37

1.0

ng/l

741.2

671.7

0.44

191

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

152

1.25

0.36

1.3

2.0

e6/l

40551.0

19085.7

0.24

(3011985) Renin [Units/volume] in Plasma

526

1.12

0.35

2.1

1.4

mu/l

51.8

66.8

0.49

466

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

851

1.09

0.35

2.0

1.9

pmol/l

194.1

202.1

0.35

796

(3000330) Specific gravity of Urine by Test strip

260

2473

1.05

0.34

4.6

3.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

292

1.17

0.34

1.2

1.3

mmol/l

13.7

12.0

0.35

(3002385) Erythrocyte distribution width [Ratio]

3328

33577

0.98

0.34

36.1

20.0

14.3

13.9

55.52

3252

32712

(44806420)

172

1.22

0.34

1.8

2.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.33

0.33

1.0

1.2

u/l

5.0

11.8

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

118

1.27

0.33

1.1

1.2

mmol/l

1.3

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

444

1.13

0.33

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

802

0.91

0.32

2.1

1.9

—

(4146454)

538

0.89

0.31

2.5

2.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

858

1.09

0.31

1.7

nmol/l

0.9

0.8

0.59

713

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

514

4981

1.03

0.30

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

315

1.14

0.30

1.5

nmol/l

0.5

0.3

0.58

242

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.23

0.29

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

534

0.90

0.28

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

103

1.26

0.28

1.9

1.4

ug/l

8.8

9.2

0.16

103

(21494434) Karyotype in Bone marrow

441

1.11

0.27

1.3

1.2

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.25

0.27

14.3

12.0

mmol/l

4.5

5.8

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.23

0.27

1.4

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

300

0.87

0.26

2.8

4.9

u/ml

40.6

50.4

—

(3024263) Appearance of Synovial fluid

262

1.15

0.26

1.6

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.68

0.26

4.4

6.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.68

0.26

2.2

3.1

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

463

1.10

0.25

1.6

1.3

e6/l

25455.8

116121.6

2.04

317

(3045683) HLA typing for celiac disease panel - Blood or Tissue

170

1.18

0.24

1.1

1.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

161

1.18

0.24

2.9

1.5

ug/l

5.6

5.1

0.08

133

(3045424) Erythrocytes [Presence] in Urine

703

0.92

0.23

1.7

1.5

—

(3003694) ABO and Rh group [Type] in Blood

1080

10625

1.02

0.23

1.4

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

218

1.15

0.23

1.8

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.22

0.22

1.0

1.6

nmol/l

0.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

0.21

0.0

1.0

—

167.3

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

440

1.09

0.21

1.1

u/ml

3.4

5.7

0.34

220

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

554

5420

1.02

0.20

4.3

4.7

32.8

0.03

400

3571

(3020876) Protein [Mass/time] in 24 hour Urine

441

1.09

0.20

2.0

—

1.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.20

0.0

2.8

—

12.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.20

0.0

5.8

—

404.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

229

0.87

0.20

1.5

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.13

0.18

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

1448

14319

1.01

0.18

3.7

3.2

mmol/l

7.1

7.5

4.02

1165

11829

(21491868) Cryoglobulin [Mass/volume] in Serum

147

1.16

0.18

1.0

1.2

g/l

—

0.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

185

1.14

0.18

11.2

5.6

u/ml

38.8

56.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.15

0.17

1.0

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

226

0.88

0.17

1.5

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

110

1.18

0.17

1.3

2.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

127

1324

0.96

0.17

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

129

1.16

0.17

1.1

2.1

ug/l

0.8

1.3

0.73

119

(40765096) Chromosome analysis panel by Banding

148

1.15

0.16

1.2

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

0.71

0.16

1.0

1.2

mg/l

9.1

8.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

120

0.83

0.16

1.3

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.14

0.16

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

273

1.10

0.16

1.0

u/ml

0.5

0.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

496

1.07

0.15

1.2

1.1

u/ml

2.5

2.1

0.08

200

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1025

0.96

0.15

2.4

1.9

—

(3045414) Leukocytes [Presence] in Urine

183

1885

0.97

0.14

2.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

324

1.08

0.14

1.1

u/ml

1.6

2.6

0.44

129

(3014051) Protein [Presence] in Urine by Test strip

998

0.96

0.12

2.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

4364

43742

0.99

0.11

35.4

19.9

mmol/l

4.0

1.19

4236

42424

(3006270) Folate [Moles/volume] in Blood

445

0.94

0.11

1.4

1.2

nmol/l

308.0

335.4

0.45

355

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

105

1.14

0.11

2.3

1.2

umol/l

4.4

3.7

0.40

(3020874) Milk IgE Ab [Units/volume] in Serum

136

0.88

0.11

1.2

1.1

u/ml

0.3

1.5

—

(3047189) Immunofixation for 24 hour Urine

260

1.08

0.10

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

115

0.87

0.10

2.8

1.9

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

241

1.08

0.10

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

427

1.05

0.10

1.1

u/ml

0.5

1.3

0.94

186

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

261

1.07

0.10

1.3

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

261

1.07

0.10

1.3

1.5

—

(3025130) Human papilloma virus identified in Specimen

232

1.08

0.09

1.7

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.06

0.09

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

489

1.04

0.08

1.3

1.4

pmol/l

338.7

267.9

0.48

371

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

123

0.89

0.08

1.2

1.3

34.0

30.0

—

(3022145) Colonoscopy Study observation

462

4571

1.01

0.07

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.86

0.07

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

196

1.07

0.07

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

701

0.97

0.07

1.5

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

182

0.93

0.05

1.2

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

1.11

0.05

5.8

5.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

114

1159

0.98

0.04

1.8

nmol/l

41.8

42.5

0.12

106

1115

(3010726) Horse dander IgE Ab [Units/volume] in Serum

389

1.03

0.03

1.2

1.1

u/ml

0.7

2.2

1.51

101

(3020650) Glucose [Presence] in Urine

1.09

0.03

2.8

1.6

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

4363

43650

1.00

0.02

35.6

19.8

mmol/l

139.1

139.6

20.65

4239

42408

(3000034) Microalbumin [Mass/volume] in Urine

457

0.98

0.01

3.5

3.1

mg/l

56.2

38.6

0.35

352

(3048879) Bone marrow aspiration report

154

1.04

0.00

1.5

1.6

—

(4133840)

100

1.00

0.00

1.0

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

271

1.00

0.00

2.0

2.1

ug/min

34.5

210.7

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

109

1.01

0.00

2.1

2.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

165

1.03

0.00

1.5

1.2

g/l

35.7

39.3

—

(3037556) Urate [Mass/volume] in Serum or Plasma

149

1.01

0.00

1.2

1.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

109

1094

1.00

0.00

1.7

1.6

—

(4024509)

438

1.00

0.00

1.9

1.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

164

1638

1.00

0.00

1.1

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.1

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.2

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

69.2

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

1.00

0.00

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.91

0.00

1.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.7

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.96

0.00

1.2

1.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.92

0.00

1.0

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

0.0

1.5

—

3120.0

—

(3029075) Extractable nuclear Ab panel - Serum

0.96

0.00

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_EXTERLUNG and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_EXTERLUNG	3.808 [3.36, 4.31]	< 0.001
Birth year	0.998 [0.99, 1.01]	0.541

During the follow-up period (1.1.1998 — 31.12.2019), 6547 out of 12360 females with J10_EXTERLUNG died.

Males

Parameter	HR [95% CI]	p-value
J10_EXTERLUNG	3.701 [3.25, 4.21]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 11681 out of 21009 males with J10_EXTERLUNG died.

Mortality risk

Mortality risk for people of age

years, who have J10_EXTERLUNG.

N-year risk	Females	Males
1	0.464%	0.573%
5	2.347%	3.661%
10	5.493%	8.851%
15	9.994%	15.792%
20	18.381%	25.671%

Relationships between endpoints

↥

Index endpoint: J10_EXTERLUNG – Lung diseases due to external agents

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Lung diseases due to external agents

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints